Skip to main content
Caplight Logo









Apostle Inc.

Apostle Inc.

Private
Pleasanton, CaliforniaHealthcare & Life Scienceshttps://apostlebio.com/

Last Round

Series A

May 24, 2019

Total Funding Raised

$5.6M

Company Overview

Apostle Inc. is a biotechnology company that provides innovative technologies and services for public health and life sciences, specializing in nucleic acid isolation and preservation for liquid biopsy and noninvasive prenatal testing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Usage-Based SaaS

AI Layer

Non-AI

Keywords

nucleic acid extractionliquid biopsymagnetic nanoparticlesextracellular vesiclescell-free DNAcfDNAsample preparationgenomic analysislab automationbiotech reagentsclinical diagnosticssample prep kitsmolecular diagnosticsnext-generation sequencingNGSCRO services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Apostle Inc. Comparables

Compare Apostle Inc. with similar companies based on industry and business-model similarity.

Apostle Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Danaher Corporation
82%
Nonacus
81%
CellBio Scientific
80%

Apostle Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 24, 2019
AcceleratorApr 3, 2018
SeedApr 3, 2017

Key People

Founding team and executive leadership

David Ge

CEO Founder

Founding Team

Apostle Inc. Investors

Notable investors and investment history

Apostle Inc. investors
InvestorRounds
StartXSeries A
Westlake VenturesSeed
Amino CapitalSeries A, Seed
ShangBay CapitalSeed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 26, 2025

    Gladstone Institutes added as a mid-market customer.

  • Mar 26, 2025

    Added Immersive Computing Lab, a startup in Academia/Research, as a customer.

Apostle Inc. Filings

Explore SEC and related filing metadata, where available.

Apostle Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Apostle Inc.'s valuation, stock price, and market status.

Is Apostle Inc. a public or private company?

Apostle Inc. is a private company.

What is the current stock price of Apostle Inc.?

Apostle Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Apostle Inc. worth (valuation)?

Valuation information for Apostle Inc. is not publicly available.

Can I buy Apostle Inc. stock?

Apostle Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Apostle Inc.'s last funding round?

Apostle Inc.'s most recent funding round was Series A on May 24, 2019.

Who are the main investors in Apostle Inc.?

Key investors in Apostle Inc. include ShangBay Capital.

Will Apostle Inc. IPO soon?

No public IPO plans have been announced for Apostle Inc..

How can I track Apostle Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Apostle Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPleasanton, California
Employee Range18
Year Founded2017
Last FundingMay 24, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?